BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jetty V, Glueck CJ, Wang P, Shah P, Prince M, Lee K, Goldenberg M, Kumar A. Safety of 50,000-100,000 Units of Vitamin D3/Week in Vitamin D-Deficient, Hypercholesterolemic Patients with Reversible Statin Intolerance. N Am J Med Sci 2016;8:156-62. [PMID: 27114973 DOI: 10.4103/1947-2714.179133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Carallo C, Capozza A, Gnasso A. Effects of Vitamin D Supplementation in Patients with Statin-Associated Muscle Symptoms and Low Vitamin D Levels. Metabolic Syndrome and Related Disorders 2022. [DOI: 10.1089/met.2021.0127] [Reference Citation Analysis]
2 Teo CB, Tan PY, Tay RYK, Khoo J, Watts GF, Loh WJ. Association Between Vitamin D Supplementation and Statin-Associated Muscle Symptoms: A Systematic Review. High Blood Press Cardiovasc Prev 2022;29:337-51. [PMID: 35768686 DOI: 10.1007/s40292-022-00526-5] [Reference Citation Analysis]
3 Hou Q, Pang C, Chen Y. Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis. Am J Cardiovasc Drugs 2022;22:183-93. [PMID: 34296397 DOI: 10.1007/s40256-021-00492-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Vinci P, Panizon E, Tosoni LM, Cerrato C, Pellicori F, Mearelli F, Biasinutto C, Fiotti N, Di Girolamo FG, Biolo G. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy. Int J Mol Sci 2021;22:11687. [PMID: 34769118 DOI: 10.3390/ijms222111687] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
5 McCullough PJ, McCullough WP, Lehrer D, Travers JB, Repas SJ. Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications. Nutrients 2021;13:1511. [PMID: 33947070 DOI: 10.3390/nu13051511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Bartlomiejczyk MA, Penson P, Banach M. Vitamin D and SAMS. Contemporary Cardiology 2020. [DOI: 10.1007/978-3-030-33304-1_14] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Turner RM, Pirmohamed M. Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components. J Clin Med 2019;9:E22. [PMID: 31861911 DOI: 10.3390/jcm9010022] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 28.0] [Reference Citation Analysis]
8 Taylor BA, Thompson PD. Statin-Associated Muscle Disease: Advances in Diagnosis and Management. Neurotherapeutics 2018;15:1006-17. [PMID: 30251222 DOI: 10.1007/s13311-018-0670-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
9 Gröber U, Schmidt J, Kisters K. Important drug-micronutrient interactions: A selection for clinical practice. Crit Rev Food Sci Nutr 2020;60:257-75. [PMID: 30580552 DOI: 10.1080/10408398.2018.1522613] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
10 Malihi Z, Wu Z, Lawes CMM, Scragg R. Adverse events from large dose vitamin D supplementation taken for one year or longer. J Steroid Biochem Mol Biol 2019;188:29-37. [PMID: 30529281 DOI: 10.1016/j.jsbmb.2018.12.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
11 Hilton-Jones D. Statin-related myopathies. Pract Neurol 2018;18:97-105. [PMID: 29496886 DOI: 10.1136/practneurol-2017-001738] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
12 Katsiki N, Kolovou G, Perez-Martinez P, Mikhailidis DP. Dyslipidaemia in the elderly: to treat or not to treat? Expert Rev Clin Pharmacol 2018;11:259-78. [PMID: 29303009 DOI: 10.1080/17512433.2018.1425138] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 du Souich P, Roederer G, Dufour R. Myotoxicity of statins: Mechanism of action. Pharmacology & Therapeutics 2017;175:1-16. [DOI: 10.1016/j.pharmthera.2017.02.029] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 17.4] [Reference Citation Analysis]
14 Glueck CJ, Lee K, Prince M, Milgrom A, Makadia F, Wang P. Low serum vitamin D, statin associated muscle symptoms, vitamin D supplementation. Atherosclerosis 2017;256:125-7. [PMID: 28007301 DOI: 10.1016/j.atherosclerosis.2016.11.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
15 Taylor BA, Lorson L, White CM, Thompson PD. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain. Atherosclerosis 2017;256:100-4. [PMID: 27993387 DOI: 10.1016/j.atherosclerosis.2016.11.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]